Product Details for NDA 050578
FORTAZ (CEFTAZIDIME)
500MG/VIAL
Marketing Status: Discontinued
1GM/VIAL
Marketing Status: Discontinued
2GM/VIAL
Marketing Status: Discontinued
6GM/VIAL
Marketing Status: Discontinued
500MG/VIAL
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 001
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FORTAZ (CEFTAZIDIME)
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 001
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
1GM/VIAL
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 002
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FORTAZ (CEFTAZIDIME)
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 002
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2GM/VIAL
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 003
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FORTAZ (CEFTAZIDIME)
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 003
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
6GM/VIAL
Marketing Status: Discontinued
Active Ingredient: CEFTAZIDIME
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 6GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 004
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: FORTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 6GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050578
Product Number: 004
Approval Date: Jul 19, 1985
Applicant Holder Full Name: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
Marketing Status: Discontinued
Patent and Exclusivity Information